ADMA Biologics, Inc. ( ADMA) - Stock Earnings
ADMA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 36.4 million USD | 134.2 million USD |
| 2025Q4 | 49.4 million USD | 139.2 million USD |
| 2026Q1 | 45.3 million USD | 114.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ADMA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.2 million USD | 258.2 million USD |
| 2024 | 197.7 million USD | 426.5 million USD |
| 2025 | 146.9 million USD | 510.2 million USD |
| 2026 Est. | — | — |
ADMA
Price: $8.50
52 week price:
Earnings Per Share: 0.68 USD
P/E Ratio: 11.59
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -13.6 millionMarket Capitalization: 1.9 billion